Community news

Lao Saal, Associate Professor at Lund University and founder of SAGA Diagnostics, is the subject of an extensive new feature published by Lund University. Earlier this spring, SAGA Diagnostics was acquired by Foundation Medicine, part of Roche, in a deal valued at up to USD 595 million. The story follows …

This summer, we are investing in a series of upgrades to the event facilities at Inspira, creating an even more welcoming, accessible and inspiring environment for meetings, conferences and events. The refurbishment includes an improved entrance area with enhanced accessibility, a refreshed foyer featuring new surface materials designed to improve …

The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise – enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. STOCKHOLM and LUND, Sweden, 15 June 2026 — Pelago Bioscience, …

Last week, life science went to Folkemødet when we and Malin Bornschein at Medeon mingled, networked, and explored opportunities for collaboration, in a visit organised by Öresundsinstitutet. During the two days of Folkemødet on Bornholm, political parties, grassroots organisations, and representatives from civil society, business, and the cultural sector come …

Welcome to Almedalsveckan in Visby next week and to our new initiative, ”Life Science-dagen”, on Wednesday 24 June. We will also be part of another new initiative, ”Skånes Innovationsarena”, the following day. Both these initiatives will take place at the same location – in our large tent at with a …

Skåne companies are optimistic about workforce growth, but the region’s high share of small and early-stage companies means that specialised external expertise plays a particularly important role. Some facts to prove it: 46% of Skåne respondents expanded their internal workforce in 2025, while 23% reduced it. Looking ahead, 61% expect …

N23 Health, a femtech company developing AI support for portable breast cancer screening equipment, has been accepted into the incubator program at SmiLe Venture Hub. Ongoing clinical studies show highly promising results, where the combination of AI and ultrasound performs at levels comparable to physician assessments. N23 Health’s solution combines …

Mellan den 12 juni och 18 juni satsar vi extra på tillgänglighet och erbjuder fler bokningsbara tider varje dag. Nya tider släpps i Kry- appen kl. 07.00 varje morgon. Du kan också boka tid genom att ringa oss på 046-378 28 00.

Excited to be recognized as one of five European Digital Innovation Hub (EDIH) Community Award finalists at the EDIH Summit 2026! This recognition belongs to HealthHub Finland EDIH (HHFIN) and the joint work behind the initiative “Towards Simplified Regulatory Compliance: A Comprehensive …

VERIGRAFT, a Swedish clinical-stage biotechnology company developing personalized, fully biological therapies, and TFS HealthScience, a full-service global contract research organization (CRO), today announced their collaboration on the pivotal Phase II/III trial of VERIGRAFT’s P-TEV (personalized tissue-engineered vein) in patients with chronic venous insufficiency (CVI).  Chronic venous insufficiency is a progressive …

How can European cities and regions strengthen their health and life science ecosystems through collaboration, peer learning, and exchange of good practices? This was the focus when Lund welcomed partners from across Europe for a three-day study visit as part of the Interreg Europe HEALTH CITIES …

Yesterday, happy villagers and neighbours from the surrounding area gathered for the final Science After Work before the summer break. The Japanese Garden, our new outdoor terrace at Inspira, was officially inaugurated on stage, and Niklas Sellin, Construction Project Manager at Medicon Village, took the opportunity to present …